Clinical Evaluation of the ARIES Group B Streptococcus (GBS) Assay

NCT02497430 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 918

Last updated 2016-09-15

No results posted yet for this study

Summary

The ARIES GBS Assay is a real-time PCR based qualitative test designed to detect Group B Streptococcus (GBS) nucleic acid from Lim Broth enriched vaginal-rectal specimen swabs obtained from pregnant women between 35 - 37 weeks gestation.

Conditions

  • Pregnancy
  • GBS

Sponsors & Collaborators

  • Luminex Corporation

    lead INDUSTRY

Principal Investigators

  • Ronald D Dunn · Luminex Corporation

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02497430 on ClinicalTrials.gov